Literature DB >> 18596919

Inhibition of calpains improves memory and synaptic transmission in a mouse model of Alzheimer disease.

Fabrizio Trinchese1, Mauro Fa', Shumin Liu, Hong Zhang, Ariel Hidalgo, Stephen D Schmidt, Hisako Yamaguchi, Narihiko Yoshii, Paul M Mathews, Ralph A Nixon, Ottavio Arancio.   

Abstract

Calpains are calcium-dependent enzymes that determine the fate of proteins through regulated proteolytic activity. Calpains have been linked to the modulation of memory and are key to the pathogenesis of Alzheimer disease (AD). When abnormally activated, calpains can also initiate degradation of proteins essential for neuronal survival. Here we show that calpain inhibition through E64, a cysteine protease inhibitor, and the highly specific calpain inhibitor BDA-410 restored normal synaptic function both in hippocampal cultures and in hippocampal slices from the APP/PS1 mouse, an animal model of AD. Calpain inhibition also improved spatial-working memory and associative fear memory in APP/PS1 mice. These beneficial effects of the calpain inhibitors were associated with restoration of normal phosphorylation levels of the transcription factor CREB and involved redistribution of the synaptic protein synapsin I. Thus, calpain inhibition may prove useful in the alleviation of memory loss in AD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18596919      PMCID: PMC2441853          DOI: 10.1172/JCI34254

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  69 in total

1.  Truncations of amphiphysin I by calpain inhibit vesicle endocytosis during neural hyperexcitation.

Authors:  Yumei Wu; Shuang Liang; Yoshiya Oda; Iori Ohmori; Tei-ichi Nishiki; Kohji Takei; Hideki Matsui; Kazuhito Tomizawa
Journal:  EMBO J       Date:  2007-05-31       Impact factor: 11.598

Review 2.  Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide.

Authors:  Christian Haass; Dennis J Selkoe
Journal:  Nat Rev Mol Cell Biol       Date:  2007-02       Impact factor: 94.444

Review 3.  A synaptic model of memory: long-term potentiation in the hippocampus.

Authors:  T V Bliss; G L Collingridge
Journal:  Nature       Date:  1993-01-07       Impact factor: 49.962

4.  Activation of NF-kappa B requires proteolysis of the inhibitor I kappa B-alpha: signal-induced phosphorylation of I kappa B-alpha alone does not release active NF-kappa B.

Authors:  Y C Lin; K Brown; U Siebenlist
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-17       Impact factor: 11.205

5.  Proteolytic degradation of SCOP in the hippocampus contributes to activation of MAP kinase and memory.

Authors:  Kimiko Shimizu; Trongha Phan; Isabelle M Mansuy; Daniel R Storm
Journal:  Cell       Date:  2007-03-23       Impact factor: 41.582

6.  Endogenous cleavage of phospholipase C-beta 3 by agonist-induced activation of calpain in human platelets.

Authors:  Y Banno; S Nakashima; T Hachiya; Y Nozawa
Journal:  J Biol Chem       Date:  1995-03-03       Impact factor: 5.157

7.  Differential sensitivity of FOS and JUN family members to calpains.

Authors:  S Carillo; M Pariat; A M Steff; P Roux; M Etienne-Julan; T Lorca; M Piechaczyk
Journal:  Oncogene       Date:  1994-06       Impact factor: 9.867

8.  Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration.

Authors:  K Saito; J S Elce; J E Hamos; R A Nixon
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

9.  BDA-410: a novel synthetic calpain inhibitor active against blood stage malaria.

Authors:  Xuerong Li; Huiqing Chen; Jong-Jin Jeong; Athar H Chishti
Journal:  Mol Biochem Parasitol       Date:  2007-05-18       Impact factor: 1.759

10.  The phosphorylation state of GluR1 subunits determines the susceptibility of AMPA receptors to calpain cleavage.

Authors:  Eunice Y Yuen; Wenhua Liu; Zhen Yan
Journal:  J Biol Chem       Date:  2007-04-11       Impact factor: 5.157

View more
  103 in total

1.  Endocannabinoids prevent β-amyloid-mediated lysosomal destabilization in cultured neurons.

Authors:  Janis Noonan; Riffat Tanveer; Allan Klompas; Aoife Gowran; Joanne McKiernan; Veronica A Campbell
Journal:  J Biol Chem       Date:  2010-10-05       Impact factor: 5.157

2.  Furoxans (1,2,5-oxadiazole-N-oxides) as novel NO mimetic neuroprotective and procognitive agents.

Authors:  Isaac T Schiefer; Lawren VandeVrede; Mauro Fa'; Ottavio Arancio; Gregory R J Thatcher
Journal:  J Med Chem       Date:  2012-03-30       Impact factor: 7.446

3.  Calpain inhibition attenuates angiotensin II-induced abdominal aortic aneurysms and atherosclerosis in low-density lipoprotein receptor-deficient mice.

Authors:  Venkateswaran Subramanian; Haruhito A Uchida; Talha Ijaz; Jessica J Moorleghen; Deborah A Howatt; Anju Balakrishnan
Journal:  J Cardiovasc Pharmacol       Date:  2012-01       Impact factor: 3.105

4.  The ankyrin repeat-rich membrane spanning (ARMS)/Kidins220 scaffold protein is regulated by activity-dependent calpain proteolysis and modulates synaptic plasticity.

Authors:  Synphen H Wu; Juan Carlos Arévalo; Veronika E Neubrand; Hong Zhang; Ottavio Arancio; Moses V Chao
Journal:  J Biol Chem       Date:  2010-10-13       Impact factor: 5.157

5.  Preparation of oligomeric beta-amyloid 1-42 and induction of synaptic plasticity impairment on hippocampal slices.

Authors:  Mauro Fa; Ian J Orozco; Yitshak I Francis; Faisal Saeed; Yimin Gong; Ottavio Arancio
Journal:  J Vis Exp       Date:  2010-07-14       Impact factor: 1.355

6.  Calpastatin inhibits motor neuron death and increases survival of hSOD1(G93A) mice.

Authors:  Mala V Rao; Jabbar Campbell; Arti Palaniappan; Asok Kumar; Ralph A Nixon
Journal:  J Neurochem       Date:  2016-03-23       Impact factor: 5.372

7.  Calcium signaling and neurodegenerative diseases.

Authors:  Ilya Bezprozvanny
Journal:  Trends Mol Med       Date:  2009-02-21       Impact factor: 11.951

Review 8.  The dysregulation of intracellular calcium in Alzheimer disease.

Authors:  Charlene Supnet; Ilya Bezprozvanny
Journal:  Cell Calcium       Date:  2010-01-18       Impact factor: 6.817

9.  Apoptosis and in vitro Alzheimer disease neuronal models.

Authors:  P Calissano; C Matrone; G Amadoro
Journal:  Commun Integr Biol       Date:  2009

Review 10.  Behavioral assays with mouse models of Alzheimer's disease: practical considerations and guidelines.

Authors:  Daniela Puzzo; Linda Lee; Agostino Palmeri; Giorgio Calabrese; Ottavio Arancio
Journal:  Biochem Pharmacol       Date:  2014-01-21       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.